A.P. Pharma, Inc. (NASDAQ:APPA)
CAPS Rating:
A specialty pharmaceutical company focused on developing pharmaceutical products using its proprietary Biochronomer polymer-based drug delivery technology.
A specialty pharmaceutical company focused on developing pharmaceutical products using its proprietary Biochronomer polymer-based drug delivery technology.